Effects of Different Strategy of Fluids Administration on Acid/Base

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Aim of the study is to ascertain whether a different strategy of fluids administration can be responsible of differences in terms of acid/base disorders (Stewart approach), pro-inflammatory and inflammatory mediators. Hence two groups of patients will be treated either with not-balanced solutions (Normal Saline) or balanced solutions

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT05195502` - Mapping the Human Colon Using Single Cell Sequencing

NCT number	NCT01320891
Study type	Interventional
Source	Università degli Studi di Ferrara
Contact
Status	Completed
Phase	N/A
Start date	February 2010
Completion date	February 2012

Effects of Different Strategy of Fluids Administration on Acid/Base Disorders and Inflammatory Mediators

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms